Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3584]

Fighting cancer is more efficient at dawn

Fighting cancer is more efficient at dawn

SABCS 2022: First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in patients with aggressive breast cancer

SABCS 2022: First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in...

Newfound cancer cell biology suggests which patients will respond to immunotherapy

Newfound cancer cell biology suggests which patients will respond to immunotherapy

Simultaneous radiation and immunotherapy are beneficial for a subset of lung cancer patients

Simultaneous radiation and immunotherapy are beneficial for a subset of lung cancer patients

DCVax-L vaccination improves survival for newly diagnosed and recurrent glioblastoma

DCVax-L vaccination improves survival for newly diagnosed and recurrent glioblastoma

CAR T cell therapy reaches beyond cancer

CAR T cell therapy reaches beyond cancer

Drug triggers immune cells to attack prostate cancer

Drug triggers immune cells to attack prostate cancer

Study finds common, targetable mechanism tumours use to suppress immune responses

Study finds common, targetable mechanism tumours use to suppress immune responses

Parsing the genetic drivers of head and neck cancers

Parsing the genetic drivers of head and neck cancers

Analysis reveals adverse effects of complex cancer therapies called antibody drug conjugates

Analysis reveals adverse effects of complex cancer therapies called antibody drug conjugates

More from ecancer